CID 67177778

Mtor inhibitor

Structural Information

Molecular Formula
C25H30N8O2
SMILES
CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4=NC=CC=N4)C(=N2)N5CCOCC5C
InChI
InChI=1S/C25H30N8O2/c1-3-26-25(34)29-19-7-5-18(6-8-19)22-30-21-15-32(24-27-10-4-11-28-24)12-9-20(21)23(31-22)33-13-14-35-16-17(33)2/h4-8,10-11,17H,3,9,12-16H2,1-2H3,(H2,26,29,34)
InChIKey
WQBAZXIQANTUOY-UHFFFAOYSA-N
Compound name
1-ethyl-3-[4-[4-(3-methylmorpholin-4-yl)-7-pyrimidin-2-yl-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-yl]phenyl]urea
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

9
Patents

474.24918 Da
Monoisotopic Mass

2.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 475.25646 219.8
[M+Na]+ 497.23840 223.1
[M-H]- 473.24190 224.4
[M+NH4]+ 492.28300 217.0
[M+K]+ 513.21234 215.7
[M+H-H2O]+ 457.24644 203.4
[M+HCOO]- 519.24738 227.3
[M+CH3COO]- 533.26303 223.1
[M+Na-2H]- 495.22385 222.0
[M]+ 474.24863 214.1
[M]- 474.24973 214.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe